Author:
Bai Minghua,Wang Baofeng,Wang Xijing,Ma Hongbing,Wang Yali,Wang Zhongwei
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Bissery MC, Nohynek G, Sanderink GJ, et al. Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anti-cancer Drugs, 1995, 6: 339–355.
2. Mason KA, Hunter NR, Milas M, et al. Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res, 1997, 3: 2431–2438.
3. Amorino GP, Hamilton VM, Choy H. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro. Radiat Oncol Investig, 1999, 7: 343–352.
4. Smorenburg CH, Sparreboom A, Bontenbal M, et al. Combination chemotherapy of the taxanes and antimetabolites: its use and limitations. Eur J Cancer, 2001, 37: 2310–2323.
5. Posner MC, Minsky BD, Ilson DH. Cancer of the esophagus. In: Devita VT (ed). Cancer principles & practice of oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2011. 887–923.